Mitotic regulation of the Golgi apparatus- the role of the ARF nucleotide exchange factor GBF1
高尔基体的有丝分裂调节——ARF核苷酸交换因子GBF1的作用
基本信息
- 批准号:BB/F005628/1
- 负责人:
- 金额:$ 36.76万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2008
- 资助国家:英国
- 起止时间:2008 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
All cells from animals, plants and fungi are made up of different compartments, each with a unique composition and specific functions. Material is transported between these many of these compartments, or organelles, in membrane-bound packets called vesicles. This process, referred to as membrane traffic, is required for the correct functioning of cells, and organisms as a whole. For example hormones, antibodies, neurotransmitters, and the major components of skin, cartilage and bone are released from cells in vesicles that fuse with the cell surface, while growth factors and dead cells are removed from the bloodstream in vesicles that are taken up from the cell surface. One of the major compartments in cells is the Golgi apparatus, a collection of flattened membrane sacks called cisternae that are layered on top of each other to form stacks. The Golgi apparatus has two major functions: it is responsible for modifying sugar chains present on proteins and lipids; and the packaging of these molecules into transport vesicles for delivery to the cell surface or other compartments in the cell. Proper modification and delivery of proteins is of fundamental importance. Defects in Golgi function, and membrane traffic in general, are responsible for a number of human diseases. Furthermore, components of the membrane traffic machinery, including those at the Golgi apparatus, are hijacked by certain bacteria and viruses, allowing these pathogens to replicate and/or avoid detection by the immune system. It is therefore important we understand how the Golgi apparatus functions at the molecular level. When cells divide organelles are inherited by the daughter cells. For the Golgi apparatus, this involves fragmentation into smaller structures, and requires the modification of key Golgi components. We have recently identified one of these components as GBF1, a protein known to be important for membrane traffic at the Golgi apparatus. The modification of GBF1 during cell division suggests it plays an important role in Golgi inheritance. In this project we aim to investigate how GBF1 is modified, and how this modification is important for the division of the Golgi apparatus and cells as a whole. This will increase our knowledge of how cells divide, which is relevant to many diseases including cancer. We also plan to determine how GBF1 is recruited to the Golgi, which is important for our understanding of membrane traffic in all cells, including those that are not dividing. Finally, since GBF1 is targeted by viruses such as poliovirus, our work will provide new insights into how these viral pathogens influence GBF1 function, which will inform better design of therapeutic strategies against them.
动物、植物和真菌的所有细胞都由不同的隔室组成,每个隔室都有独特的组成和特定的功能。物质在这些隔间或细胞器之间运输,在称为囊泡的膜结合包中。这一过程被称为膜运输,是细胞和整个生物体正常运作所必需的。例如,激素、抗体、神经递质以及皮肤、软骨和骨骼的主要成分从细胞中释放出来,并与细胞表面融合,而生长因子和死细胞则从细胞表面吸收的囊泡中从血流中去除。高尔基体是细胞中的一个主要区室,它是一组扁平的膜袋,称为池,它们彼此层叠形成堆叠。高尔基体有两个主要功能:它负责修饰蛋白质和脂质上的糖链;以及将这些分子包装到运输囊泡中,以递送到细胞表面或细胞中的其他隔室。蛋白质的适当修饰和递送是至关重要的。高尔基体功能和一般膜交通的缺陷是导致许多人类疾病的原因。此外,膜运输机器的组件,包括高尔基体的组件,被某些细菌和病毒劫持,使这些病原体能够复制和/或避免被免疫系统检测到。因此,我们在分子水平上了解高尔基体的功能是很重要的。当细胞分裂时,细胞器由子细胞继承。对于高尔基体,这涉及到分裂成更小的结构,并需要修改关键的高尔基体组件。我们最近已经确定了这些组件之一的GBF 1,一种蛋白质已知是重要的膜交通在高尔基体。GBF 1在细胞分裂过程中的修饰表明它在高尔基体遗传中起重要作用。在这个项目中,我们的目标是研究如何GBF 1被修改,以及如何这种修改是重要的高尔基体和细胞作为一个整体的分裂。这将增加我们对细胞如何分裂的知识,这与包括癌症在内的许多疾病有关。我们还计划确定GBF 1是如何被招募到高尔基体的,这对于我们理解所有细胞(包括那些不分裂的细胞)中的膜交通非常重要。最后,由于GBF 1是脊髓灰质炎病毒等病毒的目标,我们的工作将为这些病毒病原体如何影响GBF 1功能提供新的见解,这将为更好地设计针对它们的治疗策略提供信息。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Lowe其他文献
High prevalence of early repolarization in the pediatric relatives of Sudden Arrhythmic Death Syndrome (SADS) victims and in normal controls
心律失常性死亡综合症 (SADS) 患者的儿科亲属和正常对照中早期复极的发生率较高
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
A. McCorquodale;R. Poulton;J. Hendry;G. Norrish;E. Field;Sarah;Mead;Martin Lowe;J. Kaski - 通讯作者:
J. Kaski
PO-04-149 strongAHEAD OF THE CURVE – EXPERIENCE FROM THE UK’S FIRST DEDICATED SPECIALIST CRM CLINIC FOR ACHD PATIENTS/strong
PO-04-149 领先于曲线——来自英国第一家专门为 ACHD 患者设立的专业 CRM 诊所的经验
- DOI:
10.1016/j.hrthm.2023.03.1273 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:5.700
- 作者:
Holly L. Daw;Ciaran Goswell;Charles Butcher;Jeremy Kalindjian;Bruna C. Di Nubila;Vinit Sawhney;Martin Lowe;Filip R. Zemrak;Vivienne A. Ezzat - 通讯作者:
Vivienne A. Ezzat
Glutamate Release from Guinea‐Pig Synaptosomes: Stimulation by Reuptake‐Induced Depolarization
豚鼠突触体中谷氨酸的释放:再摄取诱导的去极化的刺激
- DOI:
10.1111/j.1471-4159.1989.tb07296.x - 发表时间:
1989 - 期刊:
- 影响因子:4.7
- 作者:
H. McMahon;A. Barrie;Martin Lowe;D. Nicholls - 通讯作者:
D. Nicholls
PO-01-048 strongFACTORS INFLUENCING SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SCREENING SUCCESS IN PAEDIATRIC POPULATION: A TERTIARY HOSPITAL EXPERIENCE/strong
影响儿科人群皮下植入式心脏复律除颤器筛查成功的强因素:一家三级医院的经验
- DOI:
10.1016/j.hrthm.2023.03.697 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:5.700
- 作者:
Alanna Morrison;Sophie Marshall;Stacey James;Charles Butcher;Eleanor Thompson;Martin Lowe;Jasveer S. Mangat;Abdualrahman Alkanhal - 通讯作者:
Abdualrahman Alkanhal
Signalling for secretion
分泌信号
- DOI:
10.1038/ncb0905-851 - 发表时间:
2005-09-01 - 期刊:
- 影响因子:19.100
- 作者:
Yashoda Ghanekar;Martin Lowe - 通讯作者:
Martin Lowe
Martin Lowe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Lowe', 18)}}的其他基金
Understanding and treating neurogenetic conditions related to the Kennedy pathway
了解和治疗与肯尼迪通路相关的神经遗传疾病
- 批准号:
MR/Y014251/1 - 财政年份:2024
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Determining the specificity of vesicle traffic at the Golgi apparatus
确定高尔基体囊泡运输的特异性
- 批准号:
BB/X006859/1 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Coordination of membrane traffic in the early secretory pathway
早期分泌途径中膜运输的协调
- 批准号:
BB/S014799/1 - 财政年份:2019
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
A new role for intermediate filaments in the secretory pathway
中间丝在分泌途径中的新作用
- 批准号:
BB/T000945/1 - 财政年份:2019
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Mechanisms of endocytic recycling in the renal proximal tubule
肾近曲小管内吞再循环机制
- 批准号:
BB/N000641/1 - 财政年份:2016
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Dissecting the function of GORAB, the protein mutated in Geroderma osteodysplastica
剖析 GORAB 的功能,GORAB 是骨发育不良中突变的蛋白质
- 批准号:
MR/N000366/1 - 财政年份:2015
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
The role of OCRL1 in endocytic membrane traffic
OCRL1在内吞膜运输中的作用
- 批准号:
MR/K000810/1 - 财政年份:2013
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Dissecting the roles of ZFPL1 and GMAP210 in Golgi biogenesis and membrane traffic
剖析 ZFPL1 和 GMAP210 在高尔基体生物发生和膜运输中的作用
- 批准号:
BB/I007717/1 - 财政年份:2011
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
A Manchester-Beijing Strategic Parntership in Molecular Life Sciences
曼彻斯特-北京分子生命科学战略合作伙伴关系
- 批准号:
BB/H531600/1 - 财政年份:2010
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
Molecular organisation of the secretory and endocytic pathways
分泌和内吞途径的分子组织
- 批准号:
G0501725/1 - 财政年份:2006
- 资助金额:
$ 36.76万 - 项目类别:
Research Grant
相似国自然基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
- 批准号:82371634
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
- 批准号:82371379
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
- 批准号:82371770
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
- 批准号:82371651
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
- 批准号:82370798
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
- 批准号:82371801
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
- 批准号:82371028
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
- 批准号:82371150
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
- 批准号:82371284
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Regulation of Coat Proteins in the ER-Golgi System
内质网-高尔基体系统中外壳蛋白的调节
- 批准号:
RGPIN-2020-05055 - 财政年份:2022
- 资助金额:
$ 36.76万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Coat Proteins in the ER-Golgi System
内质网-高尔基体系统中外壳蛋白的调节
- 批准号:
RGPIN-2020-05055 - 财政年份:2021
- 资助金额:
$ 36.76万 - 项目类别:
Discovery Grants Program - Individual
Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent
新型高尔基体靶向抗癌剂的作用机制
- 批准号:
10407638 - 财政年份:2020
- 资助金额:
$ 36.76万 - 项目类别:
Downregulation of Rab3D: Critical Role in Golgi Disorganization and the Pathogenesis of Alcoholic Liver Disease
Rab3D 下调:在高尔基体紊乱和酒精性肝病发病机制中的关键作用
- 批准号:
10455408 - 财政年份:2020
- 资助金额:
$ 36.76万 - 项目类别:
Downregulation of Rab3D: Critical Role in Golgi Disorganization and the Pathogenesis of Alcoholic Liver Disease
Rab3D 下调:在高尔基体紊乱和酒精性肝病发病机制中的关键作用
- 批准号:
9885965 - 财政年份:2020
- 资助金额:
$ 36.76万 - 项目类别:
Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent
新型高尔基体靶向抗癌剂的作用机制
- 批准号:
10631058 - 财政年份:2020
- 资助金额:
$ 36.76万 - 项目类别:
GTPase Regulation of the Golgi Complex (Diversity Supplement 2023)
高尔基复合体的 GTPase 调节(多样性补充资料 2023)
- 批准号:
10800329 - 财政年份:2020
- 资助金额:
$ 36.76万 - 项目类别:














{{item.name}}会员




